ReviewVaccines2023
Attitudes towards Receiving Monkeypox Vaccination: A Systematic Review and Meta-Analysis.
Review in Vaccines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Mpox vaccine acceptance and its predictors among people who have risky sexual practices: A systematic review and meta-analysis.Human vaccines & immunotherapeutics · 2025Pooled it
- Global prevalence and determinants associated with the acceptance of monkeypox vaccination.Narra J · 2024Pooled it
- Willingness to receive mpox vaccine among men who have sex with men: a systematic review and meta-analysis.BMC public health · 2024Pooled it
- Mpox Vaccination Willingness, Concern Profiles, and Associated Factors Among Men Who Have Sex with Men in Changsha, China.Vaccines · 2026Article
- Effective communication and public engagement strategies to counter misinformation about infectious diseases.Immunology and cell biology · 2026Review
- Mpox Vaccination and Willingness to Participate in Mpox Vaccine Research Among Sexual and Gender Minority Adults with and Without HIV in the United States.Prevention science : the official journal of the Society for Prevention Research · 2026Article
- Advancing Infectious Diseases Control in Africa: Lessons From the Mpox Re-emergence.Health science reports · 2025Article
- Predictors of Willingness to Receive Monkeypox Vaccine in Palestine: A Cross-Sectional Study.Vaccines · 2025Article
- The Evolution of Monkeypox Vaccination Acceptance in Romania: A Comparative Analysis (2022-2025), Psychosocial Perceptions, and the Impact of Anti-Vaccination Rhetoric on Societal Security.Behavioral sciences (Basel, Switzerland) · 2025Article
- Unlocking the potentials of community health workers for effective control of mpox outbreaks in Africa.The Pan African medical journal · 2025Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe public's attitude towards Mpox vaccination is a critical factor in the success of immunisation programmes. Understanding the factors contributing to vaccine acceptance or hesitancy is critical for developing effective health communication strategies. This systematic review and meta-analysis aims to bring together evidence from observational studies on attitudes towards Mpox vaccination, including willingness and rejection.
methodsFrom this review's inception until June 2023, a comprehensive search was conducted across four major electronic databases: PubMed, Web of Science, Scopus, and EBSCO. The inclusion criteria included studies investigating public attitudes towards Mpox vaccination, as defined by acceptance and willingness to be vaccinated versus rejection and unwillingness.
resultsThirty studies met the inclusion criteria among the screened literature. An analysis of 27 studies involving 81,792 participants revealed that 45,926 (56.14%) were willing to receive the Mpox vaccination. In contrast, ten studies involving 7448 participants revealed that 2156 people (28.94%) were unwilling to receive the Mpox vaccination. Females were less willing to receive the vaccine than males, with an odds ratio (OR) of 0.61 (95% CI, 0.43-0.86). Furthermore, homosexuals were found to be more willing than heterosexuals, with an OR of 1.44 (95% CI, 1.14-1.80).
conclusionVaccination is emerging as a critical strategy for preventing Mpox infection and fostering herd immunity against potential outbreaks. Improving public awareness and acceptance of vaccination is critical to avoiding a situation similar to the COVID-19 pandemic. Targeted educational and outreach programmes could explain the benefits of vaccination, bridging the information gap and encouraging a proactive public health approach to emerging infectious diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.